En un meta-anlisis realizado de los principales ensayos clnicos publicados se evalu el perfil de seguridad cardiovascular de la lixisenatida (ELIXA), liraglutida (LEADER), semaglutida (SUSTAIN-6) y exenatida de liberacin prolongada (EXSCEL), siendo la mortalidad cardiovascular, el infarto al miocardio no fatal y el ictus no fatal las principales variables de resultado en los ltimos tres, mientras que en el estudio ELIXA se estudi adems como variable principal la hospitalizacin por angina inestable
Causes of Hair Loss in Ozempic Users Why might hair thinning or shedding appear after starting Ozempic
Explore Weight Loss Program Success Factors Why 2025 Represents the Inflection Point for Affordable, Transparent Telehealth Weight Management The convergence of multiple macro trends positions 2025 as a defining moment for consumer-first, affordable telehealth weight loss programs prioritizing transparency, flexibility, and user autonomy over profit maximization through deceptive pricing tactics
Curr Biol 8 , 873876 (1998)
Ask about third-party testing, sterility protocols, and ingredient sourcing